Clinical TrialsSearch results
Number of results: 213
Other
- Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart Failure
- Chronic heart failure
- J-CHF Study Group
- 2006-12-13
Other
- Japan Cooperative SPECT Study of Mild Impairment of Cognitive Function
- Mild Cognitive Impairment
- J-COSMIC Executive Committee
- 2006-08-15
Other
- Prospective, randomized, open-label, blinded-endpoint trial to examine the effect of active vitamin D on cardiovascular events in hemodialysis patients: Japan Dialysis Active Vitamin D trial (J-DAVID)
- Chronic kidney disease stage 5D
- J-DAVID Research Group
- 2008-06-19
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Other
- Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study
- Hypertensive patients with albuminuria and diabetes (diabetic nephropathy)
- J-FLAG Study Group
- 2009-01-29
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Investigational study for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Multicenter study of a randomized controlled trial with or without maintenance/intensification therapy in patients with previously untreated acute promyelocytic leukemia (JALSG APL97 study)
- acute promyelocytic leukemia (APL)
- Japan Adult Leukemia Study Group
- 2005-09-14
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17